Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Orally Administered Single- and Multiple-Dose Olopatadine in Healthy Chinese Subjects: An Open-Label Study

By Chu Nan-Nan   Chen Wei-Li   Xu Hong-Rong   Li Xue-Ning  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 451-457

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Pitavastatin by Formulation and Ethnic Group: An Open-Label, Single-Dose, Two-Way Crossover Pharmacokinetic Study in Healthy Caucasian and Japanese Men

By Warrington Steve  

Clinical Drug Investigation, Vol. 31, Iss. 10, 2011-10 ,pp. : 735-743

Adis International

Access to resources Recommend Favorite

Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

By Nunes Teresa  

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite